SVG
Commentary
Press Release

91ÆÞÓÑ Institute Co-Releases Report on US Biodefense Readiness

Groundbreaking study examines national biodefense vulnerabilities;
Provides blueprint of recommendations to keep America safe

WASHINGTON -- Today, 91ÆÞÓÑ Institute is co-releasing , a bipartisan report produced by the Blue Ribbon Study Panel on Biodefense. The report outlines national vulnerabilities to growing biological threats and provides recommendations on improving U.S. defense against biological weapons and naturally-occurring infectious diseases.

The report was unveiled this morning at the Reserve Officers Club in Washington, D.C., during an event featuring former Governor Tom Ridge, Senator Joseph Lieberman, and 91ÆÞÓÑ Institute President Kenneth Weinstein. 91ÆÞÓÑ Institute served as one of the institutional sponsors of the Blue Ribbon Study Panel on Biodefense.

"The idea of a national commission on bioterrorism," said 91ÆÞÓÑ President Dr. Weinstein, "came out of 91ÆÞÓÑ's firm belief that the federal government was giving insufficient attention to a looming homeland security problem, especially at a time when radical Islam is a growing force around the globe."

91ÆÞÓÑ Institute hosted the Blue Ribbon Study Panel series, convening executive stakeholders throughout government, academia, and the private sector, for targeted and extensive discussion on the state of U.S. biodefense. The panels featured former administration and congressional officials, including Joseph Lieberman, Thomas Ridge, Donna Shalala, Thomas Daschle, James Greenwood and Kenneth Wainstein.

91ÆÞÓÑ Distinguished Fellow Mike Rogers, a former Congressman and chair of the House Intelligence Committee, contributed a congressional perspective to the study's panel on biodefense response and recovery. 91ÆÞÓÑ Senior Vice President Lewis Libby, who led Pentagon efforts in the first Gulf War to mitigate biological and chemical weapons, served as an ex officio member of the panel, in addition to 91ÆÞÓÑ Adjunct Fellow Tevi Troy, former Deputy Secretary of the U.S. Department of Health and Human Services.

provides a clear schedule of short-, medium- and long-term action items and programmatic, legislative and policy recommendations to bring about a coordinated biodefense platform under the leadership of the Vice President. Conclusions in the report are the result of a year-long program of high-level panels, public meetings, targeted interviews and extensive research.

The full report, , can be accessed here: To arrange an interview, please contact Carolyn Stewart